Matrix Membranes

Matrix Membranes is a bioprocessing technology company specializing in the development of high-performance functionalized membranes for the life sciences industry. The company's proprietary technology addresses critical bottlenecks in downstream processing by providing membranes with significantly higher binding capacities and flow rates compared to traditional chromatography resins. These solutions are optimized for the purification of complex biologics, including monoclonal antibodies, recombinant proteins, and vaccines. By improving purification efficiency, Matrix Membranes enables biopharmaceutical manufacturers to reduce production costs and accelerate time-to-market for new therapies. The company is headquartered in the United Kingdom and focuses on scaling its technology for global biomanufacturing applications.